Loading insider details...
Beta
Latest Form 4 (Sep 30, 2026): Conversion of 10,690,530 ADRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | ADARx Pharmaceuticals, Inc. (ADRX) | Conversion | 10,690,530 | n/a |
| Sep 23, 2026 | Electra Therapeutics, Inc. (ETRA) | Conversion | 2,002,310 | n/a |
| Aug 12, 2026 | BlossomHill Therapeutics, Inc. (BLSM) | Conversion | 1,039,996 | n/a |
| Aug 10, 2026 | BlossomHill Therapeutics, Inc. (BLSM) | Grant/Award | 23,904 | n/a |
| Jul 29, 2026 | Scribe Therapeutics, Inc. (SCTX) | Conversion | 348,825 | n/a |
| Jul 28, 2026 | Scribe Therapeutics, Inc. (SCTX) | Grant/Award | 14,725 | n/a |
| Jan 5, 2026 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 90,000 | n/a |
| Dec 18, 2025 | Keros Therapeutics, Inc. (KROS) | Disposition to Issuer | 140,057 | $2.49M |
| Jun 6, 2025 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 5,250 | n/a |
| Apr 11, 2025 | Compass Therapeutics, Inc. (CMPX) | Sale | 3,571,428 | $5.68M |